- Home
- JFU vs TXMD Comparison
JFU vs TXMD Comparison
Compare JFU & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JFU | TXMD |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 24.3M |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | JFU | TXMD |
|---|---|---|
| Price | $2.68 | $2.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.1K | ★ 29.8K |
| Earning Date | 12-09-2022 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $1.43 | $108.75 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $1.98 | $0.99 |
| 52 Week High | $9.48 | $2.95 |
Technical Indicators
Market Signals| Indicator | JFU | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 54.44 |
| Support Level | $2.06 | $2.15 |
| Resistance Level | $2.94 | $2.31 |
| Average True Range (ATR) | 0.25 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 52.17 | 43.75 |
Price Performance
Historical ComparisonAbout JFU 9F Inc.
9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.